Survival in stage IV non-small cell lung cancer patients based on radiation dose to immune cells: a retrospective analysis
In the IT era, higher EDRIC is associated with poorer OS and PFS, and the combination of EDRIC, lymphocyte nadir, and Advanced Lung Cancer Inflammation Index (ALI) provides more accurate prognostic assessment of OS than any single parameter alone.
Authors
- Shuanghu Yuan (ORCID: https://orcid.org/0000-0002-8327-2524)
- T. W. Hu
- Fuhao Xu (ORCID: https://orcid.org/0009-0008-0015-6714)
- Changxing Feng
- Li Li
- Kang Wang
Institutions
- University of Science and Technology of China (CN)
- Anhui Provincial Hospital (CN)
- Heze Municipal Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.3389/fonc.2025.1715751
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China